X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs NATCO PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD NATCO PHARMA MERCK LTD/
NATCO PHARMA
 
P/E (TTM) x 48.8 19.6 249.6% View Chart
P/BV x 6.4 18.7 34.2% View Chart
Dividend Yield % 0.4 0.6 72.2%  

Financials

 MERCK LTD   NATCO PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
NATCO PHARMA
Mar-14
MERCK LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060877 120.9%   
Low Rs623424 147.1%   
Sales per share (Unadj.) Rs632.4223.4 283.1%  
Earnings per share (Unadj.) Rs45.731.1 147.2%  
Cash flow per share (Unadj.) Rs62.340.3 154.7%  
Dividends per share (Unadj.) Rs11.005.00 220.0%  
Dividend yield (eoy) %1.30.8 170.0%  
Book value per share (Unadj.) Rs388.8219.5 177.1%  
Shares outstanding (eoy) m16.6033.07 50.2%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x1.32.9 45.7%   
Avg P/E ratio x18.420.9 87.9%  
P/CF ratio (eoy) x13.516.1 83.6%  
Price / Book Value ratio x2.23.0 73.1%  
Dividend payout %24.116.1 149.5%   
Avg Mkt Cap Rs m13,96921,504 65.0%   
No. of employees `0001.6NA-   
Total wages/salary Rs m1,4871,128 131.8%   
Avg. sales/employee Rs Th6,631.9NM-  
Avg. wages/employee Rs Th939.2NM-  
Avg. net profit/employee Rs Th479.4NM-  
INCOME DATA
Net Sales Rs m10,4987,389 142.1%  
Other income Rs m242167 145.1%   
Total revenues Rs m10,7417,556 142.1%   
Gross profit Rs m1,1351,793 63.3%  
Depreciation Rs m276304 90.5%   
Interest Rs m0366 0.0%   
Profit before tax Rs m1,1021,290 85.5%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343309 111.2%   
Profit after tax Rs m7591,027 73.9%  
Gross profit margin %10.824.3 44.6%  
Effective tax rate %31.123.9 130.1%   
Net profit margin %7.213.9 52.0%  
BALANCE SHEET DATA
Current assets Rs m6,4103,681 174.1%   
Current liabilities Rs m8,8283,123 282.7%   
Net working cap to sales %-23.07.6 -304.8%  
Current ratio x0.71.2 61.6%  
Inventory Days Days5889 64.5%  
Debtors Days Days3859 65.4%  
Net fixed assets Rs m1,4067,685 18.3%   
Share capital Rs m166331 50.2%   
"Free" reserves Rs m6,2866,670 94.2%   
Net worth Rs m6,4557,259 88.9%   
Long term debt Rs m0955 0.0%   
Total assets Rs m8,82811,957 73.8%  
Interest coverage xNM4.5-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.6 192.4%   
Return on assets %8.611.7 73.8%  
Return on equity %11.814.2 83.1%  
Return on capital %17.120.7 82.4%  
Exports to sales %8.339.4 21.0%   
Imports to sales %21.05.7 369.2%   
Exports (fob) Rs m8692,908 29.9%   
Imports (cif) Rs m2,209421 524.5%   
Fx inflow Rs m9593,445 27.8%   
Fx outflow Rs m2,612703 371.7%   
Net fx Rs m-1,6532,743 -60.3%   
CASH FLOW
From Operations Rs m1,0701,440 74.3%  
From Investments Rs m-750-1,089 68.8%  
From Financial Activity Rs m-150-353 42.5%  
Net Cashflow Rs m171-1 -11,469.8%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.8 1.5 3,523.8%  
Indian inst/Mut Fund % 18.2 7.8 232.1%  
FIIs % 1.0 16.6 6.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 26.0 111.9%  
Shareholders   28,591 25,395 112.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 69.6%

May 25, 2018 | Updated on May 25, 2018

For the quarter ended March 2018, NATCO PHARMA has posted a net profit of Rs 3 bn (up 69.6% YoY). Sales on the other hand came in at Rs 8 bn (up 32.9% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jun 22, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS